← Back to Clinical Trials
Recruiting NCT06469333

NCT06469333 Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Post-traumatic Symptoms.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06469333
Status Recruiting
Phase
Sponsor University of Lorraine
Condition Working Memory
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2024-09-06
Primary Completion 2026-06

Trial Parameters

Condition Working Memory
Sponsor University of Lorraine
Study Type INTERVENTIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-09-06
Completion 2026-06
Interventions
Eye movements (EM)Auditory stimulationsTactile stimulations

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

EMDR is a psychotherapeutic approach recommended by the World Health Organization (WHO) for the treatment of disorders such as post-traumatic stress disorder, anxiety, depression and, more generally, psychological distress. In all these disorders, intrusions are one of the symptoms leading to intense emotional distress. EMDR therapy, by making intrusions less emotional and less present in the mind (i.e. less vivid), would reduce psychological distress. This symptomatological reduction would be made possible by the therapist's application of alternating bilateral visual (rapid eye movements following a point from left to right), auditory (tones emitted alternately in the right ear and then in the left ear) and/or tactile (tapping with fingers on the left and right shoulders alternately) stimulations administered while the patient concentrates on his or her intrusive thoughts. Accordingly, the aim of this research is to investigate the efficacy of self-administration of Alternating Bilateral Stimulations (ABS), on the emotional intensity (emotionality) associated with negative intrusive thoughts (or intrusions).

Eligibility Criteria

Inclusion Criteria: * Present symptoms of acute stress (score between 22 and 35 on the Impact Event Scale-Revised, IES-R) and/or PTSD (higher score or equal to 36 on the IES-R), but at least present moderate to high psychological distress (score equal to or greater than 8 on the Kessler Abbreviated Psychological Distress Scale, K6); * Being in need of psychotherapeutic follow-up but not having started it yet; * Be aged between 18 and 65 years inclusive; * Speak and write French (be able to understand information and complete questionnaires independently); * Have good vision (being able to follow the movement of a white point on a screen); * Have good hearing and tactile abilities (being able to perceive auditory and tactile tones); * Have a computer equipped with a webcam; * Be informed and sign informed consent. Exclusion Criteria: * Be an adult protected under guardianship or curatorship; * Be a person subject to a judicial safeguard measure; * Present a lack of autonomy implying an

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology